Inhibition of Mammalian Legumain by Michael Acceptors and AzaAsn-Halomethylketones
- 27 January 2002
- journal article
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 383 (7-8) , 1205-14
- https://doi.org/10.1515/bc.2002.133
Abstract
Legumain is a lysosomal cysteine peptidase specific for an asparagine residue in the P1-position. It has been classified as a member of clan CD peptidases due to predicted structural similarities to caspases and gingipains. So far, inhibition studies on legumain are limited by the use of endogenous inhibitors such as cystatin C. A series of Michael acceptor inhibitors based on the backbone Cbz-L-Ala-L-Ala-L-Asn (Cbz= benzyloxycarbonyl) has been prepared and resulted in an irreversible inhibition of porcine legumain. Variation of the molecular size within the 'war head' revealed the best inhibition for the compound containing the allyl ester (kobs/I=766 M(-1) s(-1)). To overcome cyclisation between the amide moiety of the Asn residue and the 'war head', several asparagine analogues have been synthesised. Integrated in halomethylketone inhibitors, azaasparagine is accepted by legumain in the P1-position. The most potent inhibitor of this series, Cbz-L-Ala-L-Ala-AzaAsn-chloromethylketone, displays a k(obs)/I value of 139,000 M(-1) s(-1). Other cysteine peptidases, such as papain and cathepsin B, are not inhibited by this compound at concentrations up to 100 microM. The synthetic inhibitors described here represent useful tools for the investigation of the structural and physiological properties of this unique asparagine-specific peptidase.Keywords
This publication has 34 references indexed in Scilit:
- Inhibition of 3C Protease from Human Rhinovirus Strain 1B by Peptidyl BromomethylketonehydrazidesArchives of Biochemistry and Biophysics, 1999
- Structure-based design of non-peptidic pyridone aldehydes as inhibitors of interleukin-1β converting enzymeBioorganic & Medicinal Chemistry Letters, 1997
- Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damageProceedings of the National Academy of Sciences, 1997
- Cloning, Isolation, and Characterization of Mammalian Legumain, an Asparaginyl EndopeptidaseJournal of Biological Chemistry, 1997
- Hairpin loop mutations of chicken cystatin have different effects on the inhibition of cathepsin B, cathepsin L and papainFEBS Letters, 1995
- Vacuolar Processing Enzyme Responsible for Maturation of Seed ProteinsJournal of Plant Physiology, 1995
- Aspartyl .alpha.-((1-Phenyl-3-(trifluoromethyl)- pyrazol-5-yl)oxy)methyl Ketones as Interleukin-1.beta. Converting Enzyme Inhibitors. Significance of the P1 and P3 Amido Nitrogens for Enzyme-Peptide Inhibitor BindingJournal of Medicinal Chemistry, 1994
- Synthesis of a potent, reversible inhibitor of interleukin-1β converting enzymeBioorganic & Medicinal Chemistry Letters, 1992
- Vinylogous amino acid esters: a new class of inactivators for thiol proteasesJournal of Medicinal Chemistry, 1984
- An Efficient Synthesis of Optically Active α-(t-Butoxycarbonylamino)-aldehydes from α-Amino AcidsSynthesis, 1983